Skip to main content
Caplight Logo









BryoSphere Biotechnologies

BryoSphere Biotechnologies

Private
VancouverHealthcare & Life Scienceshttps://bryosphere.ca/

Last Round

Pre Seed

Sep 7, 2026

Total Funding Raised

$297,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

BryoSphere Biotechnologies is a biotechnology company that utilizes a proprietary moss-based biomanufacturing platform to produce high-performance, plant-derived bioactive ingredients for the skincare and beauty industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Fashion & Beauty, Sustainable Materials

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

biomanufacturingbioactive ingredientsskincare ingredientsclean beautymoss-based manufacturingphotobioreactorhyperpigmentationsustainable ingredientsgreen chemistrycosmetic activessynthetic biologyB2B ingredient supplierplant-derived compoundsbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BryoSphere Biotechnologies Comparables

Compare BryoSphere Biotechnologies with similar companies based on industry and business-model similarity.

BryoSphere Biotechnologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ayana Bio
76%
Core Biogenesis
75%
Naolys
73%

BryoSphere Biotechnologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedSep 7, 2026
GrantJun 16, 2025

BryoSphere Biotechnologies Investors

Notable investors and investment history

BryoSphere Biotechnologies investors
InvestorRounds
Cape Breton Capital GroupPre Seed
Okanagan Women Angel FundsPre Seed
SOSVAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 7, 2026

    $275K round with Cape Breton Capital Group and Okanagan Women Angel Funds.

  • Jun 16, 2025

    $22K grant received.

BryoSphere Biotechnologies Filings

Explore SEC and related filing metadata, where available.

BryoSphere Biotechnologies filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about BryoSphere Biotechnologies's valuation, stock price, and market status.

Is BryoSphere Biotechnologies a public or private company?

BryoSphere Biotechnologies is a private company.

What is the current stock price of BryoSphere Biotechnologies?

BryoSphere Biotechnologies is a private company with no public stock price. Caplight tracks BryoSphere Biotechnologies's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is BryoSphere Biotechnologies worth (valuation)?

Valuation information for BryoSphere Biotechnologies is not publicly available.

Can I buy BryoSphere Biotechnologies stock?

BryoSphere Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was BryoSphere Biotechnologies's last funding round?

BryoSphere Biotechnologies's most recent funding round was Pre Seed on September 7, 2026.

Who are the main investors in BryoSphere Biotechnologies?

Key investors in BryoSphere Biotechnologies include SOSV.

Will BryoSphere Biotechnologies IPO soon?

No public IPO plans have been announced for BryoSphere Biotechnologies.

How can I track BryoSphere Biotechnologies secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BryoSphere Biotechnologies's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersVancouver
Employee Range5
Year Founded2022
Last FundingSep 7, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?